brochure - north america cannabis market - 2015-2020
TRANSCRIPT
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative
products and their uses, its applications and wide acceptance. Owing to the medicinal and
industrial uses of the cannabis plant, cannabis market is growing rapidly. Factors like multi-
faceted applications of cannabis, expansion of licensing strategies, and automated irrigation
system among others are driving this market towards growth. This market is also tackling
some issues like volatile regulatory framework, absence of market leaders, perception
towards marijuana, and environmental hazards among others.
The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67
billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. While medical marijuana
has already been legalized across half of the states in the U.S., including California,
Washington, Colorado, and New York among others, legal use of recreational marijuana
closely, yet rapidly follows. The market is expected to be driven by a host of driving factors
such as adoption of Information Technology and Automation, Application of Hydroponic,
and Increasing popularity of e-cigarettes with cannabis oil among others. However, the
highly volatile regulatory framework, marijuana stigma, and the highly fragmented supply
chain will continue to challenge the market through the forecast period.
BIS RESEARCH 2015
www.bisresearch.com ©2015|BIS
Key questions answered in the report:Ÿ What are the commercial derivative products of cannabis plant?
Ÿ What are the different application areas of cannabis plant and its derivatives?
Ÿ Which is the most sought-after distribution channel in the market?
Ÿ What are the prominent consortiums, compliances, and regulatory bodies in this market?
Ÿ What are the different factors driving the market in the forecast period?
Ÿ What are the factors challenging the growth of Cannabis Market in North America?
Ÿ Who are the different participants in the North American Cannabis Market?
Ÿ What new strategies adopted by existing market players to make a mark in the industry?
Ÿ Which state will lead the Cannabis Market by the end of forecast period?
Analysis & Forecast:
Base Year: 2014
6 Year Annual Estimated Forecast
(2015-2020)
Emphasis on Legal and Regulatory
Framework Market, By Derivative:
Marijuana and Industrial Hemp
Market, By Application: Medical,
Recreational, Food & Baby Care, Clothing
& Textile, and Others
Market, By Geography: The U.S.
(including California, Washington,
Colorado, and New York among others),
Canada
2014 2015 2016 2017 2018 2019 2020
Marijuana
Industrial Hemp
0.0
2,000.0
4,000.0
6,000.0
8,000.0
10,000.0
12,000.0
14,000.0
16,000.0
18,000.0
XXXX XXXX XXXX XXXX XXXX XXXX XXXX
XXXX XXXX XXXX XXXX XXXX XXXX XXXX
www.bisresearch.com ©2015|BIS
Table of Contents
1 RESEARCH METHODOLOLOGY, SCOPE AND 5.3.2 ABSENCE OF MARKET LEADERS AND COVERAGE STANDARDS
1.1 SCOPE OF THE STUDY 5.3.3 THE ISSUES OF PERCEPTION (REPUTATION OF MARIJUANA)/MARIJUANA STIGMA1.2 RESEARCH METHODOLOGY
5.3.4 FEDERAL LEVEL CHALLENGES1.2.1 OVERALL MARKET ESTIMATION AND FORECAST 5.3.4.1 Lack of availability of bank loans to set up
operations due to federal banking prerequisites1.2.2 BIS RESEARCH METHODOLOGY5.3.4.2 Federal ban on growing industrial hemp forcing the 1.3 REPORT DESCRIPTION
market players to import raw hemp
5.3.5 HIGHLY FRAGMENTED SUPPLY CHAIN2 EXECUTIVE SUMMARY5.3.6 ENVIRONMENTAL HAZARDS
3 INTRODUCTION TO NORTH AMERICAN 6 NORTH AMERICA CANNABIS INDUSTRY CANNABIS MARKET
ANALYSIS3.1 CANNABIS MARKET EVOLUTION AND TREND6.1 PORTER’S FIVE FORCES ANALYSIS3.2 THE CANNABIS ECOSYSTEM IN NORTH 6.1.1 THREAT OF NEW ENTRANTSAMERICA: ESTIMATE AND FORECAST6.1.1.1 Entry Barriers (Government Policy and Capital 3.3 THE OPTIMISTIC ESTIMATE FOR THE U.S.
Requirements)MRIJUANA MARKET6.1.1.2 Access to distribution channels3.4 TAX REVENUE ESTIMATION FOR THE U.S.
MARIJUANA MARKET 6.1.1.3 Economies of Scale
6.1.1.4 Product Differentiation
4 KEY STRATEGIES AND DEVELOPMENT IN THE 6.1.2 BARGAINING POWER OF BUYERSNORTH AMERICAN CANNABIS MARKET (2013- 6.1.2.1 Concentration of Buyers2015) 6.1.2.2 Importance of Volume to Buyers
4.1 INTRODUCTION 6.1.2.3 Threat of Backward Integration4.2 MERGERS AND ACQUISITIONS 6.1.2.4 Buyer’s Information about Supplier’s Product4.3 PARTNERSHIP, COLLABORATION & JOINT 6.1.2.5 The existence of Black Market
VENTURES6.1.2.6 Switching Cost
4.4 PRODUCT LAUNCH6.1.2.7 Legal and Regulatory Framework
4.5 BUSINESS EXPANSION6.1.2.8 Presence of Substitutes
4.6 PRODUCT TESTING6.1.3 BARGAINING POWER OF SUPPLIERS
4.7 OTHERS6.1.3.1 Supplier Concentration
6.1.3.2 Threat of forward integration5 MARKET DYNAMICS
6.1.3.3 Product Differentiation5.1 INTRODUCTION
6.1.3.4 Switching Cost5.2 MARKET DRIVERS
6.1.4 THREAT FROM SUBSTITUTES5.2.1 AUTOMATION TRANSFORMING THE CANNABIS
6.1.4.1 Buyer’s Propensity towards SubstituteINDUSTRY
6.1.4.2 Consumer’s Switching Cost5.2.1.1 Collaboration of the Vending and Cannabis industry
6.1.5 INTENSITY OF COMPETITIVE RIVALRY5.2.1.2 Automated Irrigation Systems and Fertigation
6.1.5.1 Customer’s Loyalty Towards Brand5.2.2 INCREASING ADOPTION OF INFORMATION
6.1.5.2 Intermittent Over CapacityTECHNOLOGY IN THE CANNABIS INDUSTRY6.1.5.3 Product Differentiation5.2.3 RAPID ADOPTION OF CANNABIS FOR MEDICAL 6.1.5.4 Industry ConcentrationPURPOSES6.1.5.5 Entry Barriers5.2.4 MULTI-FACETED APPLICATIONS OF CANNABIS
DERIVATIVES 6.1.5.6 Exit barriers
5.2.5 THE PROFITABLE INTEGRATION OF THE 6.2 VALUE CHAIN ANALYSISHYDROPONICS AND CANNABIS INDUSTRY 6.2.1 INTRODUCTION
5.2.6 THE COMBINED EFFECT OF VAPER'S 6.2.2 CANNABIS GROWERS/PRODUCERSPREFERENCE FOR CANNABIS OIL AND 6.2.3 PHARMACEUTICAL COMPANIESINCREASING ADOPTION OF E-CIGARETTE
6.2.3.1 Research Facilities5.3 MARKET CHALLENGES
6.2.4 PROCESSING INDUSTRIES5.3.1 HIGHLY VOLATILE REGULATORY FRAMEWORK
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
6.2.5 PACKAGING INDUSTRIES 8.1.3 INDUSTRIAL HEMP
6.2.6 DISPENSARIES 8.1.3.1 Market statistics
6.2.6.1 Retail 8.1.3.2 Key Players
6.2.6.2 Medical 8.1.4 OTHER CONCENTRATES/PRODUCTS
6.2.6.3 Retail Outlets 8.1.4.1 Kief
8.1.4.2 Hash
7 REGULATORY & LEGAL FRAMEWORK, 8.1.4.3 Hash OilCONSORTIUMS AND COMPLIANCES 8.1.4.4 Tinctures
7.1 INTRODUCTION 8.1.4.5 Infusions7.2 REGULATORY BODIES
7.2.1 HEALTH CANADA- MARIJUANA FOR MEDICAL 9 MARKET SIZING- ESTIMATION, ANALYSIS & PURPOSES REGULATIONS (MMPR) FORECAST BY APPLICATION
7.2.2 COUNCIL ON RESPONSIBLE CANNABIS 9.1 INTRODUCTIONREGULATION (CRCR) 9.1.1 MARKET STATISTICS
7.2.3 NATIONAL ORGANIZATION FOR THE REFORM 9.2 APPLICATIONS OF MARIJUANAOF MARIJUANA LAWS (NORML)
9.2.1 MEDICINAL APPLICATIONS7.3 LEGAL FRAMEWORK
9.2.1.1 Market Statistics7.3.1 FEDERAL MARIJUANA LAW- CONTROLLED
9.2.1.2 Key PlayersSUBSTANCE ACT (CSA)9.2.2 RECREATIONAL APPLICATION OF MARIJUANA7.3.2 MARIJUANA CONTROL ACT 20149.2.2.1 Market Statistics7.3.3 HEMP FARMING ACT 20159.3 APPLICATIONS OF INDUSTRIAL HEMP7.4 COMPLIANCES9.3.1 FOOD AND BABY CARE7.4.1 MASSACHUSETTS MARIJUANA COMPLIANCE9.3.1.1 Market statistics7.4.2 MARIJUANA ENFORCEMENT TRACKING 9.3.2 CLOTHING & TEXTILEREPORTING COMPLIANCE (METRC)9.3.2.1 Market Statistics7.5 CONSORTIUMS9.3.3 OTHER HEMP PRODUCTS7.5.1 AMERICAN HERBAL PRODUCTS ASSOCIATION
(AHPA) 9.3.3.1 Market Statistics
7.5.2 ASSOCIATION OF RESPONSIBLE CANNABIS PUBLIC COMPANIES (ARCPC) 10 MARKET SIZING ANALYSIS & FORECAST, BY
7.5.3 HEMP INDUSTRIES ASSOCIATION (HIA) MARKET DEMAND
7.5.4 DRUG POLICY ALLIANCE 10.1 INTRODUCTION
7.5.5 INTERNATIONAL ASSOCIATION FOR 10.1.1 MARKET STATISTICSCANNABINOID MEDICINE (IACM) 10.2 THE U.S.
7.5.6 NATIONAL CANNABIS INDUSTRY ASSOCIATION 10.2.1 MARKET STATISTICS(NCIA) 10.2.2 CALIFORNIA
7.5.7 CANADIAN MEDICAL CANNABIS INDUSTRY 10.2.3 COLORADOASSOCIATION (CMCIA)
10.2.4 WASHINGTON7.5.8 CALIFORNIA CANNABIS INDUSTRY
10.2.5 ARIZONAASSOCIATION (CCIA)10.2.6 MICHIGAN7.5.9 ILLINOIS CANNABIS INDUSTRY ASSOCIATION10.2.7 OREGON7.5.10 NORTH AMERICAN INDUSTRIAL HEMP 10.2.8 OTHERSCOUNCIL INC. (NAIHC)10.2.9 LEGAL & REGULATORY FRAMEWORK7.5.11 CANADIAN HEMP TRADE ALLIANCE (CHTA)10.2.9.1 MARIJUANA7.5.12 KENTUCKY HEMP INDUSTRIES
ASSOCIATION(KYHIA) 10.2.9.2 INDUSTRIAL HEMP
8 MARKET SIZING – ESTIMATION, ANALYSIS & 10.2.10 KEY MARKET PLAYERSFORECAST BY DERIVATIVE 10.3 CANADA
8.1 INTRODUCTION 10.3.1 MARKET STATISTICS8.1.1 MARKET STATISTICS 10.3.2 KEY MARKET PLAYERS8.1.2 MARIJUANA/FLOWERS
8.1.2.1 Market statistics 11 KEY MARKET PLAYERS PROFILE8.1.2.2 Key Players 11.1 GROWERS
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
11.1.1 CANADIAN CANNABIS CORPORATION 11.3.1.2 Financials
11.1.1.1 Company Overview 11.3.1.2.1 Overall Financials
11.1.1.2 Financials 11.3.1.2.2 Financial Summary
11.1.1.2.1 Overall Financials 11.3.1.3 Key Developments
11.1.1.2.2 Financial Summary 11.3.2 CANNABICS PHARMACEUTICALS INC.
11.1.1.3 Key Developments 11.3.2.1 Company Overview
11.1.2 PLANDAI BIOTECHNOLOGY 11.3.2.2 Financial Summary
11.1.2.1 Company Overview 11.3.2.3 Key Developments
11.1.2.2 Financials 11.3.3 CANNABIS SCIENCE, INC.
11.1.2.2.1 Overall Financials 11.3.3.1 Company Overview
11.1.2.2.2 Financial Summary 11.3.3.2 Financials
11.1.2.3 Key Developments 11.3.3.2.1 Overall Financials
11.1.3 TWEED MARIJUANA INC. 11.3.3.2.2 Financial Summary
11.1.3.1 Company Overview 11.3.3.3 Key Developments
11.1.3.2 Financials 11.3.4 GW PHARMACEUTICALS
11.1.3.2.1 Overall Financials 11.3.4.1 Company Overview
11.1.3.2.2 Financial Summary 11.3.4.2 Financials
11.1.3.3 KEY DEVELOPMENTS 11.3.4.2.1 Overall Financials
11.1.4 AFFINOR GROWERS 11.3.4.2.2 Revenue By Segment
11.1.4.1 Company Overview 11.3.4.2.3 Revenue by Region
11.1.4.2 FINANCIALS 11.3.4.2.4 Financial Summary
11.1.4.2.1 Overall Financials 11.3.4.3 Key Developments
11.1.4.2.2 Financial Summary 11.3.5 HEMP, INC.
11.1.4.3 Key Developments 11.3.5.1 Company Overview
11.2 PRODUCERS 11.3.5.2 Financials
11.2.1 CANNABIS SATIVA INC. 11.3.5.2.1 Overall Financials
11.2.1.1 Company Overview 11.3.5.2.2 Financial Summary
11.2.1.2 Financials 11.3.5.3 Key Developments
11.2.1.2.1 Overall Financials 11.3.6 INSYS THERAPEUTICS
11.2.1.2.2 Financial Summary 11.3.6.1 Company Overview
11.2.1.3 Key Developments 11.3.6.2 Financials
11.2.2 CANNAVEST 11.3.6.2.1 Overall Financials
11.2.2.1 Company Overview 11.3.6.2.2 Revenue BY Segment
11.2.2.2 Financials 11.3.6.2.3 Financial Summary
11.2.2.2.1 Overall Financials 11.3.6.3 Key Developments
11.2.2.2.2 Financial summary 11.3.7 MEDICAL MARIJUANA INC.
11.2.2.3 Key Developments 11.3.7.1 Company Overview
11.2.3 CANNA BRANDS INC. 11.3.7.2 Financials
11.2.3.1 Company Overview 11.3.7.2.1 Overall Financials
11.2.3.2 Financial summary 11.3.7.2.2 Financial Summary
11.2.3.3 Key Developments 11.3.7.3 Key Developments
11.2.4 OMNICANNA HEALTH SOLUTIONS 11.3.8 22ND CENTURY GROUP, INC.
11.2.4.1 Company Overview 11.3.8.1 Company Overview
11.2.4.2 Financial Summary 11.3.8.2 FINANCIALS
11.2.4.3 Key Developments 11.3.8.2.1 Overall Financials
11.2.5 PRIVATEER HOLDINGS, INC. 11.3.8.2.2 Financial Summary
11.2.5.1 Company Overview 11.3.8.3 Key Developments
11.2.5.2 Key Developments 11.3.9 OTSUKA PHARMACEUTICAL CO. LTD
11.3 PHARMACEUTICAL & RESEARCH COMPANIES 11.3.9.1 Company Overview
11.3.1 ARENA PHARMACEUTICALS, INC. 11.3.9.2 Financials
11.3.1.1 Company Overview 11.3.9.2.1 Overall Financials
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
11.3.9.2.2 Revenue by Segment 11.6.1.1 Company Overview
11.3.9.2.3 Revenue by Region 11.6.1.2 Financials
11.3.9.2.4 Financial Summary 11.6.1.2.1 Overall Financials
11.3.9.3 KEY DEVELOPMENTS 11.6.1.2.2 financial Summary
11.3.10 SANOFI PHARMACEUTICALS 11.6.1.3 Key Development
11.3.10.1 Company Overview 11.7 OTHERS
11.3.10.2 Financials 11.7.1 ABATTIS BIOCEUTICALS CORPORATION
11.3.10.2.1 Overall Financials 11.7.1.1 Company Overview
11.3.10.2.2 Financial Summary 11.7.1.2 Financials
11.4 INFORMATION TECHNOLOGY 11.7.1.2.1 Overall Financials
11.4.1 AGRISOFT DEVELOPMENT GROUP 11.7.1.2.2 Financial summary
11.4.1.1 Company overview 11.7.1.3 Key Developments
11.4.1.2 Key Developments 11.7.2 CANNABIS THERAPY CORPORATION
11.4.2 ENDEXX CORPORATION 11.7.2.1 Company Overview
11.4.2.1 Company Overview 11.7.2.2 Financials
11.4.2.2 Financials 11.7.2.2.1 Overall Financials
11.4.2.2.1 Overall Financials 11.7.2.2.2 Financial summary
11.4.2.3 Key Developments 11.7.2.3 Key Developments
11.4.3 GREEN TECHNOLOGY SOLUTIONS INC. (GTSO) 11.7.3 CANNACARE DOCS
11.4.3.1 Company Overview 11.7.3.1 Company Overview
11.4.3.2 Financials 11.8 APPLICATION (APPS) COMPANIES
11.4.3.2.1 Overall Financials 11.8.1 MASS ROOTS
11.4.3.2.2 Financial Summary 11.8.1.1 Company Overview
11.4.3.3 Key Developments 11.8.2 EAZE
11.4.4 QUANTUM 9 11.8.2.1 Company Overview
11.4.4.1 Company Overview 11.8.2.2 Key Developments
11.4.4.2 Financials 11.8.3 WEEDMAPS
11.4.4.3 Key Developments 11.8.3.1 Company Overview
11.5 EQUIPMENT & INFRASTRUCTURE 11.8.4 MEADOW
11.5.1 ADVANCED CANNABIS SOLUTIONS 11.8.4.1 Company Overview
11.5.1.1 Company Overview 11.8.4.2 Key Developments
11.5.1.2 Financials 11.8.5 NESTDROP
11.5.1.2.1 Overall Financials 11.8.5.1 Company Overview
11.5.1.2.2 Revenue by Segment 11.8.5.2 Key Developments
11.5.1.2.3 Financial Summary 11.8.6 LEAFLY
11.5.1.3 Key Developments 11.8.6.1 Company Overview
11.5.2 MEDBOX, INC. 11.8.7 GRASSP
11.5.2.1 Company Overview 11.8.7.1 Company Overview
11.5.2.2 Financials 11.8.8 DAVE
11.5.2.2.1 Overall Financials 11.8.8.1 Company Overview
11.5.2.2.2 Financial Summary 11.8.9 FRWEED PRO
11.5.2.3 Key Developments 11.8.9.1 Company Overview
11.5.3 SURNA, INC.
11.5.3.1 Company Overview
11.5.3.2 Financials
11.5.3.2.1 Overall Financials
11.5.3.2.2 Financial Summary
11.5.3.3 Key Developments
11.6 ADVISORY SERVICES AND EDUCATION
11.6.1 CANNA GROW HOLDINGS
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
TABLE 1 TIMELINE OF MEDICAL MARIJUANA LEGALIZATION
TABLE 2 THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020
TABLE 3 FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE
TABLE 4 COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM
TABLE 5 CANNABIS SATIVA VS CANNABIS INDICA
TABLE 6 NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020
TABLE 7 NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020
TABLE 8 NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
TABLE 9 NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 10 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 11 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020
TABLE 12 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020
TABLE 13 NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020
TABLE 14 DISEASES & CURE BY CANNABIS
TABLE 15 INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA
TABLE 16 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE,2015-2020
TABLE 17 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 18 NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY,2015-2020
TABLE 19 NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 20 NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 21 NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
TABLE 22 NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020
TABLE 23 THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 24 THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
TABLE 25 THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020
TABLE 26 MARIJUANA LEGALIZATION DETAILS BY STATES
TABLE 27 MARIJUANA POSESSION DETAILS
TABLE 28 INDUSTRIAL HEMP POSESSION DETAILS
TABLE 29 CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
TABLE 30 CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
List of Tables
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
FIGURE 1 BIS RESEARCH METHODOLOGY
FIGURE 2 THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY
FIGURE 3 CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020
FIGURE 4 CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020
FIGURE 5 CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020
FIGURE 6 THE CANNABIS ECOSYSTEM WITH KEY PLAYERS
FIGURE 7 AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014)
FIGURE 8 KEY MERGERS & ACQUISITIONS (2013-15)
FIGURE 9 KEY PARTNERSHIPS & COLLABORATIONS (2013-15)
FIGURE 10 KEY PRODUCT LAUNCHES (2013-15)
FIGURE 11 KEY BUSINESS EXPANSION ACTIVITIES (2013-15)
FIGURE 12 KEY PRODUCT TESTING ACTIVITIES (2013-15)
FIGURE 13 OTHER KEY DEVELOPMENTS (2013-15)
FIGURE 14 BENEFITS OF USING CANNABIS VENDING MACHINES
FIGURE 15 WHY CANNABIS INDUSTRY NEEDS STANDARDS
FIGURE 16 NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER’S FIVE FORCES
FIGURE 17 NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS
FIGURE 18 FEATURE OF MMPR
FIGURE 19 MISSION OF CRCR
FIGURE 20 MISSION OF NORML
FIGURE 21 PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA
FIGURE 22 ARCPC MISSION
FIGURE 23 HIA MISSION
FIGURE 24 DPA MISSION
FIGURE 25 STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY
FIGURE 26 KEY FEATURES OF NCIA
FIGURE 27 CMCIA MISSION
FIGURE 28 NAIHC MISSION
FIGURE 29 KEY VARIETIES OF CANNABIS STRAINS
FIGURE 30 THE PSYCHOACTIVE EFFECTS OF MARIJUANA
FIGURE 31 MEDICAL BENEFITS OF MARIJUANA
FIGURE 32 INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP
FIGURE 33 APPLICATIONS OF CANNABIS PLANT
FIGURE 34 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 35 NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 36 APPLICATIONS OF INDUSTRIAL HEMP
FIGURE 37 NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 38 NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 39 NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
FIGURE 40 LEGALIZATION STATUS OF CANNABIS
FIGURE 41 CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 42 PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 43 TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION)
List of Figures
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
FIGURE 44 AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 45 CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 46 CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 47 ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 48 CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 49 GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION)
FIGURE 50 REVENUE BY SEGMENT 2012-14
FIGURE 51 REVENUE BY REGION2012-2014
FIGURE 52 HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION)
FIGURE 53 INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 54 MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 55 22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 56 OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 57 SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION)
FIGURE 58 ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 59 GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION)
FIGURE 60 ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION)
FIGURE 61 MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION)
FIGURE 62 SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 63 CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION)
FIGURE 64 ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION)
FIGURE 65 CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION)
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020
www.bisresearch.com ©2015|BIS
About BIS (www.bisresearch.com)
BIS Research provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for
the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not
be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express
written consent of BIS Research. Customer will not disclose the contents of the report, whether directly in any media or indirectly through
incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other
information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation
contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a
number of estimates and assumptions that, while considered reasonable by BIS Research as of the date of such statements, are
inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies
BIS Research
9100 West Bloomington Freeway,
Suite 159 Bloomington,
MN 55431
E-mail : [email protected]
Call Us : +1-650-228-0182
Global Delivery Center
A-21, Kailash Colony,
New Delhi,
India
Tel : +91 11 46120391
For more details regarding permission, please contact us:
North America Cannabis Market: Focus on Application, Derivative, and Region
– Estimation & Forecast, 2015-2020